China Pharma Holdings (CPHI) Current Leases: 2009-2025
Historic Current Leases for China Pharma Holdings (CPHI) over the last 6 years, with Sep 2025 value amounting to $70,326.
- China Pharma Holdings' Current Leases rose 16.74% to $70,326 in Q3 2025 from the same period last year, while for Sep 2025 it was $70,326, marking a year-over-year increase of 16.74%. This contributed to the annual value of $39,323 for FY2024, which is 49.41% down from last year.
- Latest data reveals that China Pharma Holdings reported Current Leases of $70,326 as of Q3 2025, which was up 255.61% from $19,776 recorded in Q1 2025.
- In the past 5 years, China Pharma Holdings' Current Leases ranged from a high of $86,672 in Q1 2022 and a low of $19,776 during Q1 2025.
- Its 3-year average for Current Leases is $59,577, with a median of $72,588 in 2023.
- Per our database at Business Quant, China Pharma Holdings' Current Leases slumped by 76.21% in 2023 and then spiked by 279.71% in 2024.
- Over the past 5 years, China Pharma Holdings' Current Leases (Quarterly) stood at $85,282 in 2021, then tumbled by 52.57% to $40,445 in 2022, then spiked by 92.18% to $77,727 in 2023, then tumbled by 49.41% to $39,323 in 2024, then climbed by 16.74% to $70,326 in 2025.
- Its Current Leases stands at $70,326 for Q3 2025, versus $19,776 for Q1 2025 and $39,323 for Q4 2024.